Fluidigm Showcases New Product Innovations and Research Presentations at the 2019 American Association for Cancer Research (AACR) Meeting


You May Also Like

Stemline Therapeutics Reports Fourth Quarter 2015 Financial Results

NEW YORK, March 14, 2016 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq:STML) today reported ...

AnaptysBio to Participate in Upcoming Investor Conferences

SAN DIEGO, Oct. 31, 2017 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq:ANAB), a clinical-stage biotechnology ...